Mason Street Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-30,101
| Closed | -$114K | – | 1534 |
|
|
2020
Q1 | $114K | Hold |
30,101
| – | – | ﹤0.01% | 1398 |
|
|
2019
Q4 | $153K | Buy |
30,101
+756
| +3% | +$3.84K | ﹤0.01% | 1433 |
|
|
2019
Q3 | $148K | Buy |
29,345
+1,058
| +4% | +$5.34K | ﹤0.01% | 1416 |
|
|
2019
Q2 | $175K | Buy |
28,287
+1,135
| +4% | +$7.02K | ﹤0.01% | 1389 |
|
|
2019
Q1 | $126K | Buy |
27,152
+897
| +3% | +$4.16K | ﹤0.01% | 1491 |
|
|
2018
Q4 | $110K | Buy |
26,255
+1,410
| +6% | +$5.91K | ﹤0.01% | 1447 |
|
|
2018
Q3 | $156K | Buy |
24,845
+3,557
| +17% | +$22.3K | ﹤0.01% | 1429 |
|
|
2018
Q2 | $171K | Buy |
21,288
+1,794
| +9% | +$14.4K | ﹤0.01% | 1416 |
|
|
2018
Q1 | $145K | Buy |
19,494
+1,218
| +7% | +$9.06K | ﹤0.01% | 1409 |
|
|
2017
Q4 | $109K | Buy |
18,276
+479
| +3% | +$2.86K | ﹤0.01% | 1455 |
|
|
2017
Q3 | $131K | Buy |
17,797
+479
| +3% | +$3.53K | ﹤0.01% | 1409 |
|
|
2017
Q2 | $118K | Buy |
17,318
+938
| +6% | +$6.39K | ﹤0.01% | 1415 |
|
|
2017
Q1 | $155K | Buy |
+16,380
| New | +$155K | ﹤0.01% | 1344 |
|